glp-1 shortage canada news today What happens when demand outpaces supply? The transformed the market., Caleb Silver breaks down how the FDA's shortage designation opened the door to compounded GLP-1s, increased New project announcement: HHS‑OIG is

Jody Dushay, an assistant professor of medicine at Harvard Medical School and an attending physician in endocrinology at Beth Israel Deaconess Medical Center, who prescribes weight-loss medications

January 19, 2025: Important Trial Date Set in Group Ozempic Lawsuit Many people who were harmed by Ozempic have joined the group lawsuit for GLP-1 drugs (MDL 3094: GLP-1 Products Liability Litigation)

These effects disappear when the intervention stops regardless of pharmacological activity

It is commonly prescribed for diabetes management

GLP-1 drugs (glucagon-like peptide-1s) have exploded in popularity in recent years initially as a way to control diabetes and then as tools for weight loss